GG
SRNE

Gofen & Glossberg’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Gofen & Glossberg’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$17K – 491
2017
Q3 		$17K Hold
10,000
– – ﹤0.01% 464
2017
Q2 		$20K Hold
10,000
– – ﹤0.01% 460
2017
Q1 		$40K Hold
10,000
– – ﹤0.01% 467
2016
Q4 		$49K Hold
10,000
– – ﹤0.01% 446
2016
Q3 		$77K Hold
10,000
– – ﹤0.01% 437
2016
Q2 		$56K Hold
10,000
– – ﹤0.01% 438
2016
Q1 		$54K Hold
10,000
– – ﹤0.01% 450
2015
Q4 		$87K Hold
10,000
– – ﹤0.01% 434
2015
Q3 		$84K Buy
+10,000
New +$159K ﹤0.01% 439

Other funds holding SRNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return